DEXPANTHENOL and COMA

Overview

COMA is the #5 most commonly reported adverse reaction for DEXPANTHENOL, manufactured by Laboratorios Quimica Son's, S.A. de C.V. There are 137 FDA adverse event reports linking DEXPANTHENOL to COMA. This represents approximately 2.1% of all 6,474 adverse event reports for this drug.

Patients taking DEXPANTHENOL who experience coma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COMA is a less commonly reported adverse event for DEXPANTHENOL, but still significant enough to appear in the safety profile.

Other Side Effects of DEXPANTHENOL

In addition to coma, the following adverse reactions have been reported for DEXPANTHENOL:

• OFF LABEL USE — 201 reports
• GASTROOESOPHAGEAL REFLUX DISEASE — 186 reports
• SOMNOLENCE — 162 reports
• PNEUMONIA ASPIRATION — 138 reports
• NAUSEA — 120 reports
• PYREXIA — 119 reports
• PAIN — 110 reports
• CONDITION AGGRAVATED — 108 reports
• DRUG INEFFECTIVE — 107 reports
• ANAEMIA — 106 reports

Other Drugs Associated with COMA

The following drugs have also been linked to coma in FDA adverse event reports:

Does DEXPANTHENOL cause COMA?

COMA has been reported as an adverse event in 137 FDA reports for DEXPANTHENOL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COMA with DEXPANTHENOL?

COMA accounts for approximately 2.1% of all adverse event reports for DEXPANTHENOL, making it a notable side effect.

What should I do if I experience COMA while taking DEXPANTHENOL?

If you experience coma while taking DEXPANTHENOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages